Transfer of lipophilic drugs between liposomal membranes and biological interfaces: consequences for drug delivery.
about
Natural product-based nanomedicine: recent advances and issuesLiposomes as nanomedical devicesUsing liposomes as carriers for polyphenolic compounds: the case of trans-resveratrolLiquid proliposomes of nimodipine drug delivery system: preparation, characterization, and pharmacokineticsUltrasound-guided delivery of microRNA loaded nanoparticles into cancerPLGA/liposome hybrid nanoparticles for short-chain ceramide deliveryCharacterization of the colloidal properties, in vitro antifungal activity, antileishmanial activity and toxicity in mice of a di-stigma-steryl-hemi-succinoyl-glycero-phosphocholine liposome-intercalated amphotericin B.Asymmetrical flow field-flow fractionation with on-line detection for drug transfer studies: a feasibility study.Sterically stabilized liposomes incorporating the novel anticancer agent phospho-ibuprofen (MDC-917): preparation, characterization, and in vitro/in vivo evaluationClinical development of liposome-based drugs: formulation, characterization, and therapeutic efficacyMassive Bioaccumulation and Self-Assembly of Phenazine Compounds in Live Cells.Exploring Microstructural Changes in Structural Analogues of Ibuprofen-Hosted In Situ Gelling System and Its Influence on Pharmaceutical PerformanceKinetically assembled nanoparticles of bioactive macromolecules exhibit enhanced stability and cell-targeted biological efficacyLipophilic drug transfer between liposomal and biological membranes: what does it mean for parenteral and oral drug delivery?Chlorophyll breakdown in senescent banana leaves: catabolism reprogrammed for biosynthesis of persistent blue fluorescent tetrapyrrolesOral cyclosporine A--the current picture of its liposomal and other delivery systems.Bioavailability of polyphenol liposomes: a challenge aheadRecent advances in intravenous delivery of poorly water-soluble compounds.Use of nanoscale delivery systems to maintain synergistic drug ratios in vivo.Drug delivery strategies for poorly water-soluble drugs: the industrial perspective.Recent advances in peptides for enhancing transdermal macromolecular drug delivery.Pharmaceutical liposomal drug delivery: a review of new delivery systems and a look at the regulatory landscape.Comparison of drug release from liquid crystalline monoolein dispersions and solid lipid nanoparticles using a flow cytometric techniqueNanodiscs in Membrane Biochemistry and Biophysics.Liposomal encapsulation of a near-infrared fluorophore enhances fluorescence quenching and reliable whole body optical imaging upon activation in vivo.Characterization of cationic liposomes having IL-2 expressed on their external surface, and their affinity to cervical cancer cells expressing the IL-2 receptor.Biodistribution and In Vivo Antileishmanial Activity of 1,2-Distigmasterylhemisuccinoyl-sn-Glycero-3-Phosphocholine Liposome-Intercalated Amphotericin B.Comparative study on the suitability of two techniques for measuring the transfer of lipophilic drug models from lipid nanoparticles to lipophilic acceptors.Fluorescence-quenching of a liposomal-encapsulated near-infrared fluorophore as a tool for in vivo optical imaging.Localized delivery of a lipophilic proteasome inhibitor into human skin for treatment of psoriasis.Liposomes incorporating sodium deoxycholate for hexamethylmelamine (HMM) oral delivery: development, characterization, and in vivo evaluation.Multicompartimental nanoparticles for co-encapsulation and multimodal drug delivery to tumor cells and neovasculature.Liposomal Delivery of Demineralized Dentin Matrix for Dental Tissue Regeneration.Carbamazepine mucoadhesive nanoemulgel (MNEG) as brain targeting delivery system via the olfactory mucosa.Novel insights into appropriate encapsulation methods for bioactive compounds into polymers: a study with peptides and HDAC inhibitors.Loading antimalarial drugs into noninfected red blood cells: an undesirable roommate for Plasmodium.Non-Covalent Assembly Method that Simultaneously Endows a Liposome Surface with Targeting Ligands, Protective PEG Chains, and Deep-Red Fluorescence Reporter Groups.Jumping acoustic bubbles on lipid bilayers.Investigations on the transfer of porphyrin from o/w emulsion droplets to liposomes with two different methods.Reversible glycosidic switch for secure delivery of molecular nanocargos.
P2860
Q26785633-D437B2A2-15FB-418D-A568-E957E4DF81C7Q28088315-C027FB1E-FF4C-48CE-AD2E-6AB5837C9EBBQ28482477-CC04D4A2-49CE-4B64-9288-A29422407D9AQ28706344-1D7BC679-8493-4DB7-BDD8-E5ED0F23FD19Q30386140-5F995AB7-DF66-488D-836C-2418D890F922Q34181875-347809E2-F84D-4C34-AA45-B192FA1E48FEQ34763371-B74EDE01-73B7-4F6D-9372-2570B1F4F939Q35092346-47C06903-2EF6-4FC5-9525-812A1F359C81Q35597041-3215FDEF-8601-43A3-90F8-3BC4BFF3D86EQ35679856-EB890260-CAB4-4B2E-90E6-E929FF26574BQ35778946-5DB36067-8488-49DA-9005-4E155ECCE7F0Q36360564-C3632333-6D49-4C42-94AF-D06B46E1F676Q36390180-E101606A-DE97-40A9-AFA6-BB0154988D56Q36585620-E05002CA-5FC7-468B-9CE4-CC498840D2D5Q37271297-B33122A2-6A29-49F6-B757-91A69AF9E98AQ37324276-DDBD2038-B4C2-4CB5-845E-D396C083E217Q37332632-EE4EEE43-2440-4F83-9CB3-3AC522813043Q37639306-CF4DA6AA-406B-4F0F-88ED-9498175E83FEQ37813687-7C2C99F0-AA13-4435-A2B1-BF9AE052AAD8Q37927093-59872269-7DE5-491F-856D-EF20D6490CEEQ38697294-22B9637F-5707-4A85-98B5-5407CF4A54A0Q38825691-73AC4615-3A83-4AE8-8C26-E226CB544A7DQ38950475-5277FE45-5611-4532-A95A-DB6998D51ECDQ39126044-692C0C45-9C7A-4942-8409-6270496AA6E3Q39155321-987F30B9-C1D1-427E-8110-A1F5295245ADQ39839934-D34FD828-9A31-4670-8A41-0A564453E22AQ40166247-CA1F2409-C546-4850-B6F1-C053E325F4E8Q42075019-BB041458-65BA-40AD-AC92-4A5840F34AA7Q42286003-DA07CACA-9F0B-4D86-9B16-0D19E965EE54Q42482677-37CACB4C-1F7B-4B38-B24C-885F100C67C7Q43144993-E4820374-1A02-48E2-8B43-A9113488DA61Q45374613-698D30E2-CF69-457E-AF5B-C37532B6BBC6Q47216592-18E42C76-C113-4802-9A66-83460ADCE9F0Q47573167-9EA7E232-7BD2-4B9F-81C8-B2139A87F278Q47728772-58F2EAB7-A1D5-4817-B327-C72CD2A063BDQ47917198-5A858C24-A4E8-4ECE-B56A-6B9F41D375D2Q48360404-65F9A440-3E39-414F-BC4A-DC74025EEC37Q53569051-871B3E1B-102E-4A7B-B572-EC1C1A0D2879Q54688487-BA886308-BD37-4B72-AB34-D52A361DD070Q55329893-6F0866A3-8C27-41CB-8EFB-67161725F955
P2860
Transfer of lipophilic drugs between liposomal membranes and biological interfaces: consequences for drug delivery.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Transfer of lipophilic drugs b ...... onsequences for drug delivery.
@ast
Transfer of lipophilic drugs b ...... onsequences for drug delivery.
@en
type
label
Transfer of lipophilic drugs b ...... onsequences for drug delivery.
@ast
Transfer of lipophilic drugs b ...... onsequences for drug delivery.
@en
prefLabel
Transfer of lipophilic drugs b ...... onsequences for drug delivery.
@ast
Transfer of lipophilic drugs b ...... onsequences for drug delivery.
@en
P2093
P1476
Transfer of lipophilic drugs b ...... onsequences for drug delivery.
@en
P2093
Alfred Fahr
Mathew L S Leigh
Nill Bergstrand
Peter van Hoogevest
Sylvio May
P304
P356
10.1016/J.EJPS.2005.05.012
P407
P577
2005-11-01T00:00:00Z